INJ 8H – EMA Cross & Break of Structure Confirmed

Injective has broken its descending trendline while confirming an EMA cross with the 50 EMA now above the 200 EMA. Price is holding above both EMAs ($13.29–13.33), marking a potential trend reversal structure.

Upside potential:

Next resistance zones sit at $15.00–15.50, with further continuation opening the way toward $17.00.

Downside invalidation:

A close back under the EMAs would weaken the breakout.

Major liquidity level sits lower at $12.15, where buyers previously defended.

The Stoch RSI is overbought, suggesting short-term pullback risk, but the cross + breakout adds bullish momentum to the mid-term outlook.

📊 Key focus: Can INJ sustain above $13.30–14.00 to confirm trend reversal, or will this EMA cross fail with a retest into liquidity?